Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/30/13 → 03/8/19 |
Funding
- Translational Research In Oncology: $59,440.56
Pfizer: A Randomized, Multicenter, Double-Blind Phase 3 Study of PD-0332991 (Oral CDK 4/6 Inhibitor) Plus Letrozole Versus Placebo Plus Letrozole for the Treatment of Postmenopausal Women with ER (+), HER2 (-) Breast Cancer Who Have Not...
- Cohen, Jules A (PI)
- Lu, Janice (PI)
- Kudelka, Andrzej (CoPI)
Project: Research